Recursion Pharmaceuticals, Inc. (RXRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.01 |
| Open | 8.76 |
| Bid | 8.50 x 1800 |
| Ask | 8.53 x 1800 |
| Day's range | 8.42 - 8.94 |
| 52-week range | 4.97 - 16.75 |
| Volume | |
| Avg. volume | 5,140,407 |
| Market cap | 2.023B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sale: Director Blake Borgeson Sells Shares of Recursion Pharmaceuticals Inc (RXRX)
On May 28, 2024, Blake Borgeson, Director at Recursion Pharmaceuticals Inc (NASDAQ:RXRX), executed a sale of 11,447 shares of the company.
- Insider Monkey
Hedge Funds are Loading Up on This NVIDIA Corp (NVDA) Partner Stock
We recently published a list of 7 lesser-known, under-the-radar AI stocks hedge funds are piling into. Since RXRX is part of the list, the stock deserves a deeper look. Recursion Pharmaceuticals is an NVIDIA Corp (NASDAQ:NVDA) partner that will use the semiconductor giant’s chips and technology for drug discovery. The NVIDIA Corp (NASDAQ:NVDA) “effect” is now […]
- Zacks
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
Recursion Pharmaceuticals (RXRX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
© 2024 Yahoo. All rights reserved.